The Proteomics Market

The study of proteomes extensively is known as proteomics. A group of proteins produced by a biological entity is known as a proteome. For instance, a proteome can belong to a species, for example, homo sapiens, or of an organ, for example, the liver. A proteome isn’t regular; it varies from one cell to another and changes over time. Partly, a proteome is a reflection of the basic transcriptome, which can also be described as the entire range of messenger RNA molecules present in an organism. Major propelling factors of growth in the proteomics market include surging demand for personalized medicine, increasing applications of proteomics in drug discovery, surge in demand for early diagnosis and treatment of diseases, technical advancements, increase in birth disorders and genetic disorders and the exponentially rising pharmaceutical and biopharmaceutical markets. Few other factors favoring growth are development of protein targeted treatments and precision molecular medicines for various autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Rising focus of biotechnological and pharmaceutical companies in research and development for discovering new proteomics applications, development of new drugs and proteomics biomarker discovery in various types of diseases such as cardiovascular diseases and cancer is the key trend in the global proteomics market. Proteomics is highly used in protein expression profiling, targeted protein quantitation, analysis of interactions between proteins, and post-translational modification in various segments of the pharmaceutical industry. Advanced proteomics solutions are having extensive application in diagnostic services, drug discovery and other research areas. Proteomics is a promising approach towards personalized medicine to treat number of diseases, such as diabetes, fatty liver, obesity, neurological diseases and cancer. In addition to the increasing incidence of cancer, diabetes, and other possibly fatal diseases, there is a surge in disorders, such as autism and Alzheimer's, which are significantly wanting in terms of research and cure. Use of plasma proteomics method for proteomic biomarker identification is related with challenges of patients' variation and high dynamic range of plasma proteins. However, rising focus on specialty medicines owing to technological advancements, advanced software, and tools such as IoT, data analytics, big data, and artificial intelligence in the clinical research associated to proteomics could create new opportunities for the proteomics market. However, the high cost associated to instruments is likely to hamper the market growth.

The field of nanotechnology has been associated with various proteomics applications such as phosphoproteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation and analytical detection of biomarker proteins using array techniques. This has resulted in the emergence of nanoproteomics, a science involving the application of proteomics techniques supported by nanotechnology which is creating opportunity for the market growth.

The global Proteomics Market is segregated on the basis of Equipment as Chromatography, Mass Spectroscopy, Protein Microarray, X-ray Crystallography, Protein Fractionation and Others. Based on Services the global Proteomics Market is segmented in Laboratory Service and Data Analysis and Services. Based on Application the global Proteomics Market is segmented in Drug Discovery, Clinical Diagnosis and Others.

The global Proteomics Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Proteomics Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Analysis

Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd. and others are among the major players in the global Proteomics Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

• In Feb 2021, Agilent Technologies Inc. introduced Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit aimed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.
• In Dec 2020, Thermo Fisher Scientific acquired Phitonex, Inc. Phitonex's product offering will allow Thermo Fisher to provide higher flow cytometry and imaging multiplexing abilities to meet evolving customer requirements in protein and cell analysis research.

The global Proteomics Market has been segmented as below:

Proteomics Market, By Equipment

• Chromatography
• Mass Spectroscopy
• Protein Microarray
• X-ray Crystallography
• Protein Fractionation
• Others

Proteomics Market, By Services

• Laboratory Service

• Data Analysis and Services

Proteomics Market, By Application

• Drug Discovery
• Clinical Diagnosis
• Others

Proteomics Market, By Region

• Europe
• North America
• Asia Pacific
• Rest of The World

Proteomics Market, By Company

• Hoffmann-La Roche Ltd
• GENERAL ELECTRIC COMPANY
• Bio-Rad Laboratories, Inc.
• Danaher
• Siemens Ltd.
• Thermo Fisher Scientific Inc. Inc.
• Agilent Technologies, Inc.
• Genzyme Corporation
• Biognosys AG
• Bruker
• Luminex Corporation
• Merck KGaA
• PerkinElmer Inc.
• WATERS
• Caprion Biosciences Inc.
• Fios Genomics Ltd.
• Poochon Scientific, LLC
• Applied Biomics, Inc.
• GENEWIZ
• Proteome Factory AG

The report covers the below scope:

• Global Proteomics Market sizes from 2020 to 2026, along with CAGR for 2020-2026
• Market size comparison for 2019 vs 2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to 2026
• Global Proteomics Market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Proteomics Market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2019
• Projected year - 2020
• Forecast period - 2021 to 2026

Report Scope:

The global Proteomics Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Proteomics Market share. Major industry players with significant revenue share include Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd. and others.

Why to Buy this Report:

• Gain detailed insights on the Proteomics industry trends
• Find complete analysis on the market status
• Identify the Proteomics Market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

• The report targeted towards the existing players in the industry is as follows:
• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement

 

1.      Introduction

1.1.       Key Points

1.2.      Report Description

1.3.      Markets Covered

1.4.      Stakeholders

2.     Research Methodology

2.1.      Research Scope

2.2.     Research Methodology

2.2.1.     Market Research Process

2.2.2.    Research Methodology

2.2.2.1.           Secondary Research

2.2.2.2.          Primary Research

2.2.2.3.          Models for Estimation

2.3.     Market Size Estimation

2.3.1.     Bottom-Up Approach

2.3.2.    Top-Down Approach

3.     Executive Summary

4.    Market Overview

4.1.      Introduction

4.2.     Drivers

4.3.     Restraints

4.4.     Opportunities

4.5.     Challenges

5.     Proteomics Market, By Equipment

5.1.      Key Points

5.2.  Chromatography

5.3.  Mass Spectroscopy

5.4.  Protein Microarray

5.5.  X-ray Crystallography

5.6.  Protein Fractionation

5.7.  Others

6.    Proteomics Market, By Services

6.1.      Key Points

6.2. Laboratory Service

6.3. Data Analysis and Services

7.     Proteomics Market, By Application

7.1.      Key Points

7.2.  Drug Discovery

7.3.  Clinical Diagnosis

7.4.  Others

8.    Competitive Landscape

8.1.      Introduction

8.2.     Start-up companies- Proteomics Market

8.3.     Recent Developments

8.3.1.     Mergers & Acquisitions

8.3.2.    New Product Developments

8.3.3.    Portfolio/Production Capacity Expansions

8.3.4.    Joint Ventures, Collaborations, Partnerships & Agreements

8.3.5.    Others

9.    Company Profile

9.1.  Hoffmann-La Roche Ltd

9.2. GENERAL ELECTRIC COMPANY

9.3. Bio-Rad Laboratories, Inc.

9.4. Danaher

9.5.  Siemens Ltd.

9.6. Thermo Fisher Scientific Inc. Inc.

9.7.  Agilent Technologies, Inc.

9.8. Genzyme Corporation

9.9. Biognosys AG

9.10.    Bruker

9.11.      Luminex Corporation

9.12.    Merck KGaA

9.13.     PerkinElmer Inc.

9.14.    WATERS

9.15.     Caprion Biosciences Inc.

9.16.    Fios Genomics Ltd.

9.17.     Poochon Scientific, LLC

9.18.    Applied Biomics, Inc.

9.19.    GENEWIZ

9.20.   Proteome Factory AG